Opko Health, Inc., Ten Percent Owner at Phio Pharmaceuticals, holds 2.65M shares in GeneDx Holdings (Ticker: WGS), holds 1.29M shares in Eloxx Pharmaceuticals (Ticker: ELOX), holds 2.15M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Opko Health, Inc. Sold ― shares of GeneDx Holdings on Aug 19, 2024 for an estimated value of 4.76M.
What is the percentage of profitable transactions made by Opko Health, Inc.?
The percentage of profitable transactions made by Opko Health, Inc. is 17%.
What is the average return per transaction made by Opko Health, Inc.?
The average return per transaction made by Opko Health, Inc. is 14.10%.
What stocks does Opko Health, Inc. hold?
Opko Health, Inc. holds: PHIO, ELOX, WGS, SRNE stocks.
What was Opko Health, Inc.’s latest transaction?
Opko Health, Inc. latest transaction was an Informative Sell of $4.76M.
What was Opko Health, Inc.'s most profitable transaction?
Opko Health, Inc.’s most profitable transaction was an Informative Buy of ELOX stock on August 14, 2017. The return on the trade was 171.50%.
What is Opko Health, Inc.'s role in Phio Pharmaceuticals?
Opko Health, Inc.'s role in Phio Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.